Study of the Effect of CYP3A5 Single Nucleotide Polymorphism on Tacrolimus Metabolism in Liver Transplant Patients

他克莫司 CYP3A5 基因型 肝移植 医学 单核苷酸多态性 胃肠病学 内科学 移植 基因多态性 药理学 生物 基因 遗传学
作者
Eman S. El-Hadidi,Mohamed Hussein,Manal Mohsen M Kamal El-Din,Amani Mohamed Abdel Ghani,Dina M. Habib
出处
期刊:QJM: An International Journal of Medicine [Oxford University Press]
卷期号:116 (Supplement_1)
标识
DOI:10.1093/qjmed/hcad069.187
摘要

Abstract Background Liver transplantation (LT) is currently recognized as the most effective treatment for all types of end stage liver diseases. Major advances have been made in the field of liver transplantation due to improvements in surgical techniques and organ conservation as well as optimization of intensive care and immunosuppressive management. Aim of the Work To assess the influence of CYP3A5 rs776746 gene polymorphism on tacrolimus dose and its role in individualizing tacrolimus dose in Egyptian liver transplant recipient. Patients and Methods The study included 25 liver transplant recipients and their corresponding donors. CYP3A5 gene polymorphism was done to all participants by RTPCR. For recipients, tacrolimus trough level was measured and tacrolimus weight adjusted dose was recorded. Drug concentration over dose ratio was calculated (C/D ratio). Results The present study showed that recipients carrying 3*1 and 1*1 genotypes required higher dose of tacrolimus than recipients with 3*3 genotype but was not statistical significance. Donors carrying 3*1 and 1*1 genotypes, their corresponding recepients needed higher doses of tacrolimus to achieve the desired trough levels and thus lower C/D ratio compared to recipients with donors carrying 3*3 genotype with statistically significant difference in the first month post transpalnt. Conclusion The present study revealed that recipients and grafts carrying 3*1 and 1*1 genotypes require higher dose of tacrolimus than those with 3*3 genotype. Effect of graft’s CYP3A5 genotype has higher significance than recipient’s genotype on tacrolimus dose and C/D ratio.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
一个O完成签到,获得积分10
1秒前
从容问寒完成签到 ,获得积分10
1秒前
和谐的醉山完成签到,获得积分10
2秒前
落后访风完成签到,获得积分10
2秒前
糊涂的妙之完成签到,获得积分20
2秒前
彪壮的亦瑶完成签到 ,获得积分10
3秒前
科研通AI2S应助科研通管家采纳,获得10
5秒前
SciGPT应助科研通管家采纳,获得10
5秒前
在水一方应助科研通管家采纳,获得10
5秒前
无心的鬼神完成签到,获得积分10
7秒前
lyx完成签到,获得积分10
7秒前
眠眠清完成签到 ,获得积分10
8秒前
9秒前
Amor完成签到,获得积分10
10秒前
Lion完成签到,获得积分10
10秒前
12秒前
自由的中蓝完成签到 ,获得积分10
13秒前
cavendipeng完成签到,获得积分10
14秒前
tinydog完成签到,获得积分10
16秒前
不知道完成签到,获得积分10
18秒前
jenningseastera完成签到 ,获得积分0
18秒前
阳佟天川完成签到,获得积分10
19秒前
yar应助Amor采纳,获得10
19秒前
郭自同完成签到,获得积分10
20秒前
熠熠完成签到,获得积分10
21秒前
李健应助稳重的秋天采纳,获得10
21秒前
SPUwangshunfeng完成签到,获得积分10
21秒前
爱吃糖糖完成签到 ,获得积分10
22秒前
ww完成签到,获得积分10
23秒前
ccob完成签到,获得积分10
23秒前
坐看云起完成签到,获得积分10
25秒前
无欲无求傻傻完成签到,获得积分10
26秒前
非我完成签到 ,获得积分10
26秒前
33完成签到 ,获得积分10
26秒前
秦时明月完成签到,获得积分10
27秒前
背水完成签到 ,获得积分10
27秒前
芋圆完成签到,获得积分10
27秒前
28秒前
叶123完成签到,获得积分10
30秒前
32秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Cognitive Neuroscience: The Biology of the Mind 1000
Technical Brochure TB 814: LPIT applications in HV gas insulated switchgear 1000
Immigrant Incorporation in East Asian Democracies 600
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
A Preliminary Study on Correlation Between Independent Components of Facial Thermal Images and Subjective Assessment of Chronic Stress 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3968578
求助须知:如何正确求助?哪些是违规求助? 3513406
关于积分的说明 11167631
捐赠科研通 3248853
什么是DOI,文献DOI怎么找? 1794499
邀请新用户注册赠送积分活动 875150
科研通“疑难数据库(出版商)”最低求助积分说明 804671